Orphan Drug Designation


Merrimack Pharmaceuticals Inc (MACK) Granted FDA Orphan-Drug Designation for MM-121

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that indoximod, its investigational drug candidate, was granted orphan-drug designation by the U.

Here’s Why TrovaGene Inc (TROV) Shares Are Skyrocketing Today

Investors are racing to buy TrovaGene Inc (NASDAQ:TROV) shares after the U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts